Plain-English translation of NCT06558825 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new support program designed to help women who are in treatment for trauma-related mental health conditions take and stay on PrEP (a preventive medication for HIV). The program combines education, practical skills, and motivation support delivered right in the mental health clinic where you're already getting care. Researchers want to see if this approach makes it easier for women to start and stick with this HIV prevention treatment.
Women with a history of trauma who are seeking mental health care often face barriers to starting and staying on HIV prevention medication, even when they're at higher risk. This study aims to make HIV prevention more accessible and effective by building support directly into the mental health care these women are already receiving.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the new integrated HIV prevention support program or standard mental health treatment. Those in the new program will receive education, skills training, and motivation support focused on taking and staying on HIV prevention medication — all delivered as part of your regular mental health clinic visits. The study will track whether you start the medication and how well you stick with it over time.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
United States